Warqada dawada ee dhakhtar qoray & farmashiye
KeyRx Drug List Alternatives Effective October 2022
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 1231 - 1240 ee natiijooyinka 3611
Bixiye
Insulin Pumps - Commercial
Quantity Limit
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2025
Bixiye
P25R1-20 Children’s Therapeutic Services and Supports (CTSS) Prior Authorization Requirement
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2023
Bixiye
QP112R1-20 Changes to Electronic Funds Transfer Processes
Taariikhda uu dhaqangalayo Barnaamijka: 22, Feb 2023
Bixiye
QP11-23 Commercial Pharmacy Benefit Exclusion for Cimzia®
Taariikhda uu dhaqangalayo Barnaamijka: 22, Feb 2023
Bixiye
QP12-23 Change in Prior Authorization Process for Experimental or Investigative Services
Taariikhda uu dhaqangalayo Barnaamijka: 22, Feb 2023
Bixiye
QP6-23 Commercial Pharmacy Benefit Exclusion for Briumvi™, Hemgenix®, Rebyota™, and Sunlenca® Injection
Taariikhda uu dhaqangalayo Barnaamijka: 08, Feb 2023
Bixiye
QP7-23 MHCP Pharmacy Benefit Exclusion for Briumvi™, Hemgenix®, Lunsumio™, Rebyota™, Sunlenca® Injection, and Vivimusta
Taariikhda uu dhaqangalayo Barnaamijka: 08, Feb 2023